David P. Southwell
board of directors
medical
PTC Therapeutics
Japan
Biography
David P. Southwell has served as a member of PTC's board of directors since December 2005. Mr. Southwell joined Inotek Pharmaceuticals in August 2014 as President and Chief Executive Officer. Mr. Southwell served as the Executive Vice President and Chief Financial Officer of Human Genome Sciences, a biopharmaceutical company, from March 2010 to September 2012, and from 2008 to 2010 served as a member of the company's board of directors. Prior to joining Human Genome Sciences, he served as Executive Vice President and Chief Financial Officer of Sepracor, Inc., a research-based pharmaceutical company, from June 1994 to March 2008. From August 1988 until 1994, Mr. Southwell was associated with Lehman Brothers Inc., a securities firm, in various positions with the investment banking division. Since 2007, Mr. Southwell has served on the board of directors of THL Credit, Inc. Mr. Southwell received a B.A. from Rice University and an M.B.A. from the Tuck School of Business at Dartmouth College, where he currently serves on the Board of Overseers.
Research Interest
medical
